newsfilter
← Latest News
ClinicalTrials.gov·

A Phase 1/2 Study Evaluating the Safety and Efficacy of CLBS201 in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus - NCT04990427

Serious Adverse Events, Estimated Glomerular Filtration Rate (eGFR), Serum Creatinine (SCr)